Sri Aurobindo (1872–1950) lived two extraordinary lives in one lifetime — revolutionary nationalist and visionary yogi.

From the Alipore trial to the quietude of Pondicherry, he shifted the conversation from political freedom to inner evolution. His Integral Yoga proposed something radical: not escape from the world, but transformation of it — a movement from mind to "Supermind," from human to supramental consciousness.

The Life Divine, The Synthesis of Yoga, and Savitri remain profound explorations of human potential and spiritual evolution.

A thinker of synthesis — East and West, action and contemplation, nation and cosmos.

Chronic lymphoedema may not just be about fluid. It may be about cholesterol. 🧬

In human tissue and translational mouse models, impaired lymphatic drainage led to excess dermal cholesterol deposition, adipocyte dysfunction, fibrosis, and swelling — even when plasma cholesterol was normal.

Clearing tissue cholesterol with cyclodextrin restored lymphatic architecture and reduced oedema.

Clear the cholesterol. Restore the flow

Psychedelic medicine is moving from the margins to mainstream neuroscience. 🧠✨

A recent Nature Medicine review synthesizes the biology behind the renaissance: 5-HT2A signaling, acute brain desynchronization, and a subacute plasticity window driven by BDNF–TrkB pathways.

The promise is real — rapid effects in depression, PTSD, and addiction — but so are the challenges: expectancy, unblinding, scalability, and safety.

Entropy. Plasticity. Psychiatry. 🔬

A field worth watching — carefully, rigorously, and responsibly.

Are statins as risky as labels suggest? 📊

In a 154,664-patient individual-participant meta-analysis of 23 double-blind RCTs, only 4 of 66 listed adverse effects were confirmed — mainly small, dose-related liver enzyme elevations.

No causal signal for cognitive decline, depression, sleep disturbance, neuropathy, or kidney injury.

Absolute excess risks were tiny (

Cardiovascular benefit still overwhelmingly outweighs risk. Evidence matters. 💡

IgA nephropathy remains the most common immune-mediated glomerular disease worldwide — and up to 50% of patients may progress to kidney failure within a decade. 🧬

The 2025 KDIGO guidance emphasizes early biopsy (proteinuria ≥0.5 g/day), tight BP control (

Proteinuria remains the key modifiable driver. Precision nephrology is here — and measurable. 🩺📉

Genes. Glands. Vessels. 💊

Hypertension therapy is entering a new era. The latest Lancet review highlights RNA-based silencing of angiotensinogen, selective aldosterone synthase inhibition, non-steroidal mineralocorticoid receptor antagonists, endothelin receptor blockade, and natriuretic peptide enhancement.

These therapies move beyond ACE inhibitors and ARBs toward durable, mechanism-driven blood pressure control—especially for resistant hypertension and multimorbidity.

The future may not be just lowering pressure, but reshaping pathways. 🔬🫀

☕🧠 Can your daily coffee protect your brain?

In a JAMA study of 131,821 adults followed for up to 43 years, moderate caffeinated coffee and tea intake was associated with a lower risk of dementia and modestly better cognition.

The sweet spot: 2–3 cups of coffee or 1–2 cups of tea per day. Notably, decaffeinated coffee showed no benefit.

A compelling population-level prevention signal—simple habits, long horizons, meaningful impact.

Bertrand Russell showed that clear thinking is a moral act 🧠✨

As a founder of analytic philosophy, he taught us to question assumptions, sharpen language, and let logic guide both ideas and action 📐📘

From Principia Mathematica to public debates on freedom and peace, Russell reminds us that clarity, courage, and doubt belong together 🕊️📚

🧠🩸 A finger-prick may change how we detect Alzheimer's disease.

A new Nature Medicine study shows that dried capillary blood spots can reliably measure key Alzheimer's biomarkers—p-tau217, GFAP, and neurofilament light—with strong concordance to venous plasma and cerebrospinal fluid results.

📊 In the DROP-AD multicenter study (7 sites, 337 participants), capillary p-tau217 correlated strongly with plasma (r≈0.74) and predicted amyloid pathology with good accuracy (AUC ≈0.86).

🚀 Why this matters:

• Enables minimally invasive, scalable, and potentially remote testing

• Expands access for population screening, prevention trials, and underserved groups (including Down syndrome)

• Moves us closer to earlier, equitable detection—though not yet ready for routine clinical decision-making

Small drop. Big signal. The future of Alzheimer's research may be at our fingertips. ✨

🧬 Why Coronary Artery Disease Runs in Families

Coronary artery disease is not just lifestyle—it is deeply genetic. Rare monogenic disorders like familial hypercholesterolemia and hundreds of common variants together shape lifelong risk, with polygenic risk scores identifying individuals whose inherited risk rivals traditional factors 🫀.

The good news: genetic risk is modifiable. Early LDL lowering, healthy lifestyles, and precision prevention deliver the greatest benefit in those at highest inherited risk 🔬.

A timely synthesis from The New England Journal of Medicine (2026) that reframes CAD—from destiny to opportunity.